Global Synthetic Biology Market 2014-2018

Price :
Published : Jul-2014
No. of Pages : 74

Report Description

The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment.

TechNavio’s analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018.

Covered in this Report

The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems.

TechNavio’s report, the Global Synthetic Biology Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Synthetic Biology market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Amyris Inc.
  • E. I. du Pont de Nemours and Co.
  • Thermo Fisher Scientific Inc.
  • Synthetic Genomics Inc.

Other Prominent Vendors

  • Algenol Biofuels Inc.
  • ATG:biosynthetics GmbH
  • Bayer AG
  • Bioneer Corp.
  • Biosearch Technologies Inc.
  • Bristol-Myers Squibb Co.
  • CBC Comprehensive Biomarker Center GmbH
  • Cobalt Technologies
  • Evolva Holdings SA
  • Exxon Mobil Corp.
  • GeneWorks Pty Ltd.
  • Genomatica Inc.
  • Gevo Inc.
  • Ginkgo Bioworks
  • Green Biologics Ltd.
  • New England Biolabs Inc.
  • OriGene Technologies Inc.
  • REG Life Sciences LLC
  • Royal DSM
  • Synthorx Inc.

Key Market Driver

  • Increased R&D in Synthetic Biology
  • For a full, detailed list, view our report.

Key Market Challenge

  • Lack of Modularized Biological Parts
  • For a full, detailed list, view our report.

Key Market Trend

  • Growing Demand for GM Crops
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product and Service Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Market Segmentation by Technology

08. Market Segmentation by Product

09. Market Segmentation by Applications

10. Geographical Segmentation
10.1 Synthetic Biology Market in the Americas
10.1.1 Market Size and Forecast
10.2 Synthetic Biology Market in the EMEA Region
10.2.1 Market Size and Forecast
10.3 Synthetic Biology Market in the APAC Region
10.3.1 Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Vendor Share Analysis 2013
18.3 Other Prominent Vendors

19. Key Vendor Analysis
19.1 Amyris Inc.
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Strategy
19.1.4 Geographical Segmentation
19.1.5 Key Developments
19.1.6 SWOT Analysis
19.1.7 Strengths
19.1.8 Weakness
19.1.9 Opportunities
19.1.10 Threats
19.2 E. I. du Pont de Nemours and Company
19.2.1 Key Facts
19.2.2 Business Description
19.2.3 Business Segmentation
19.2.4 Business Strategy
19.2.5 Revenue Segmentation
19.2.6 Revenue Comparison 2013-2011
19.2.7 Geographical Segmentation
19.2.8 Key Developments
19.2.9 SWOT Analysis
19.2.10 Strengths
19.2.11 Weakness
19.2.12 Opportunities
19.2.13 Threats
19.3 Synthetic Genomics, Inc.
19.3.1 Key Facts
19.3.2 Business Overview/ Description
19.3.3 Business Strategy
19.3.4 Key Information
19.3.5 SWOT Analysis
19.3.6 Strengths
19.3.7 Weakness
19.3.8 Opportunities
19.3.9 Threats
19.4 Thermo Fisher Scientific Inc.
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation
19.4.4 Revenue Segmentation by Business
19.4.5 Revenue Segmentation by Products
19.4.6 Sales by Geographical Segmentation
19.4.7 Business Strategy
19.4.8 Key Information
19.4.9 SWOT Analysis
19.4.10 Strengths
19.4.11 Weaknesses
19.4.12 Opportunities
19.4.13 Threats

20. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global Synthetic Biology Market 2013-2018 (US$ million)
Exhibit 3: Global Synthetic Biology Market Segmentation by Technology
Exhibit 4: Global Synthetic Biology Market Segmentation by Technology 2013
Exhibit 5: Global Synthetic Biology Market Segmentation by Product
Exhibit 6: Global Synthetic Biology Market Segmentation by Applications
Exhibit 7: Global Synthetic Biology Market Segmentation by Applications 2013
Exhibit 8: Global Synthetic Biology Market by Geographical Segmentation 2013
Exhibit 9: Synthetic Biology Market in the Americas 2013-2018 (US$ million)
Exhibit 10: Synthetic Biology Market in the EMEA Region 2013-2018 (US$ million)
Exhibit 11: Synthetic Biology Market in the APAC Region 2013-2018 (US$ million)
Exhibit 12: Number of Entities Conducting Research in the Global Synthetic Biology Market 2013
Exhibit 13: Amyris Inc.: Segmentation by Geography 2013
Exhibit 14: Amyris Inc.: Revenue Comparison by Geographical Segmentation 2013-2011 (US$ million)
Exhibit 15: Business Segmentation of DuPont: 2013
Exhibit 16: Revenue Segmentation of DuPont 2013
Exhibit 17: DuPont:Revenue Comparison by business segments for 2013-2011(US$ million)
Exhibit 18: DuPont by Geographical Segmentation 2013
Exhibit 19: DuPont Revenue Comparison by Geography segments for 2013-2011 (US$ million)
Exhibit 20: Business Segmentation of Thermo Fisher Scientific Inc.
Exhibit 21: Revenue by Business Segments of Thermo Fisher Scientific Inc. 2013
Exhibit 22: Revenue by Products of Thermo Fisher Scientific Inc. 2013
Exhibit 23: Sales by Geographical Segmentation of Thermo Fisher Scientific Inc. 2013

Press Release

TechNavio Announces the Publication of its Research Report - Global Synthetic Biology Market 2014-2018

TechNavio recognizes the following companies as the key players in the Global Synthetic Biology Market : Amyris Inc., E. I. du Pont de Nemours and Co., Thermo Fisher Scientific Inc., Synthetic Genomics Inc., Algenol Biofuels Inc., ATG:biosynthetics GmbH, Bayer AG, Bioneer Corp., Biosearch Technologies Inc., Bristol-Myers Squibb Co., CBC Comprehensive Biomarker Center GmbH, Cobalt Technologies, Evolva Holdings SA, Exxon Mobil Corp., GeneWorks Pty Ltd., Genomatica Inc., Gevo Inc., Ginkgo Bioworks, Green Biologics Ltd., New England Biolabs Inc., OriGene Technologies Inc., REG Life Sciences LLC, Royal DSM, Synthorx Inc.

Commenting on the report, an analyst from TechNavio’s team said: “There is growing demand for GM crops in the Agriculture industry across the world. Synthetic biology can also be used to develop crops with desirable traits such as salt-tolerance, drought-tolerance, and pest-resistance. The use of synthetic biology technologies facilitates the designing of GM crops with entirely new metabolic pathways, physiological traits, and developmental control strategies. The need to improve crops is now increasing as plants are not only considered as food, but also as a source of renewable feedstocks. This trend is expected to increase growth in the Global Synthetic Biology market over the forecast period ”

According to the report, the growth of the Global Synthetic Biology market is driven by several factors. One of the main drivers in this market is increased R&D in synthetic biology. As synthetic biology enables the development of innovative products through gene manipulation, vendors and various other research organizations are increasingly investing in R&D, so that they can offer new products in the market.

Further, the report states that one of the major challenges in the market is the lack of modularized biological parts. Lack of standardization and modularization of synthesized biological parts causes unpredictability in their function that poses a risk of the crash of the biological circuitry. Other major challenges in the market are ethical, biosafety, and biosecurity concerns.

The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Filed in: Biotechnology
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Genomics Market in the US 2014-2018

The genome is the genetic material of an individual, species or organism, which is responsible for the various functional characteristics of an individual. Genomics is an important aspect of genetics and molecular biology that focuses on the study of the structure, function, and mapping of genomes. It involves various applications in functional genomics, genome sequencing, comparative genomics, and genome analysis. A defect in genome structure or function could lead to the occurrence of disorders. Thus, genomic technologies, which identify and study defective genomes, play an important role in research, drug discovery, and disease diagnosis. These procedures require various instruments, reagents, and software for genomes sequencing and analysis. Analytical instruments such as polymerase ch......
$2500

Global Flow Cytometry Market 2014-2018

Flow cytometry is a technique of measuring the properties of cells in a fluid suspension. Flow cytometry focuses a beam of light onto a hydro dynamically focused stream of fluid. Flow cytometers can analyze thousands of particles in a short span of time. They can separate and isolate particles with specified properties. The analysis of multiple parameters of individual cells is carried out using flow cytometry. This technology is extensively used in several industries for various applications such as research, clinical trials, and diagnosis of various disorders. TechNavio's analysts forecast the Global Flow Cytometry market to grow at a CAGR of 11.23 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the growth prospects of the Gl......
$2500

Global Genomics Market 2014-2018

Genomics is the study of the genetic material or genomes of an organism. It is expected to be a strong basis for the discovery and development of diagnostic and therapeutic solutions for a range of human diseases or health conditions. Genomics is supported by three major product segments: Instruments, Consumables, and Services. The key end-users of such products include the Diagnostics market, academic and research institutions, and the Pharmaceutical industry. TechNavio's analysts forecast the Global Genomics market will grow at a CAGR of 11.21 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the growth prospects of the Global Genomics market for the period 2014-2018. To arrive at a ranking of the leading vendors of the market,......
$2500

Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018

Single Nucleotide Polymorphism (SNP) genotyping is the screening and analysis of genetic variations of SNPs in the genome of various species. SNPs are commonly present in all species including humans. SNP genotyping and analysis technology can analyze thousands of SNPs and has the potential for whole-genome genotyping. It is the most common genetic variation that occurs in the genetic makeup. It is an emerging field in life science, which provides an in-depth analysis of SNPs. It is generally used by researchers for genomics study. It has a broad range of applications in several industries such as Pharmaceuticals and Pharmacogenomics, Diagnostics Research, Agriculture Biotechnology, and Breeding and Animal Livestock. There are several technologies which are used for SNP genotyping and anal......
$2500

Global Metabolomics Market 2014-2018

Metabolomics or Metabonomics is the scientific study of chemical processes involving metabolites. Metabolomics has become a new experimental technique that is being widely used in biology, medicine and the environmental sciences. Metabolites are small molecules that are present in blood, urine, and tissues. The pattern, or fingerprint, of metabolites in a biological sample is used to learn about the health of organisms. The unique patterns of metabolites are widely used to diagnose specific diseases. A metabolome is the terminology used in metabolomics to describe the comprehensive and quantitative analysis of all the metabolites of an organism. Metabolomics is a relatively new field of omics research compared to other similar fields such as genomics, proteomics, and transcriptomics. Te......
$2500

Global Synthetic Biology Market 2014-2018

The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment. TechNavio's analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018. Covered in this Report The Global Synthetic Biology market can be......
$2500

Global Cell Culture Market 2014-2018

Cell culture is the in vitro growth of plant or animal cells for several applications such as research, cell studies, and biopharmaceutical production. Cell culture is a crucial step in tissue engineering and vaccine production. Cell culture instruments and cell culture consumables are necessary for the in vitro production of cell lines. Some essential cell culture instruments are cell culture systems, incubators, biosafety cabinets, and pipetting instruments. These instruments maintain the optimum conditions, such as temperature and humidity, that are essential for cell growth. Cell culture consumables such as media, cell culture reagents, and sera provide the essential nutrients, minerals, and supplements for cell culture. TechNavio's analysts forecast the Global Cell Culture market w......
$2500

Global Genomics and Proteomics Analytical Instruments Market 2014-2018

Genomics is the study of the gene and its functions and proteomics is the study of the structure and functions of proteomes or sets of proteins by using molecular biology and bioinformatics tools and technology. Genomics involves the mapping of genes and DNA sequencing to understand the structure and functions of genomes. A proteome is a complete set of proteins expressed by a genome at a certain time. Proteomics primarily involves the use of molecular biology, biochemistry, and genetics to analyze proteins produced by genes through the translation process. Proteins are the primary component of all cells and are responsible for the various functional characteristics of cells. A defect in the genome or proteome structure or function could result in disorders. Thus, genomics and proteomics t......
$2500

Regenerative Medicine Market in the US 2014-2018

Regenerative medicine is the branch of medicine which uses therapeutically induced or laboratory-grown human tissue to treat injured or diseased human cells, tissues, or organs. This branch of medicine focuses on repairing, replacing, or regenerating the damaged cells of the body and thus represents a paradigm shift in healthcare treatment. The two main technologies used in regenerative medicine are tissue engineering and stem cell technology. TechNavio's analysts forecast the Regenerative Medicine market in the US will grow at a CAGR of 19.88 percent over the period 2013-2018. Covered in this Report The Regenerative Medicine market in the US can be divided into 11 segments: Orthopedic Tendon and Ligament, Chronic and Acute Wounds, Cardiology, Plastic and Reconstructive Surgery, O......
$3000

Global Transcriptomics Market 2014-2018

Transcriptomics studies involve the collection and analysis of transcriptomes of different types of cells or tissues of organism. A transcriptome represents the set of all RNA molecules, which is a small part of the genetic code. The variation in genetic expression characterizes the extensive range of physical and biochemical differences among various cells and tissues and may lead to disease. It helps researchers to understand transcriptional activity in disease cause. Transcriptomics includes four prominent technologies: Microarrays, PCR, RNAi Gene Silencing Technology, and NGS technologies. TechNavio's analysts forecast the Global Transcriptomics market will grow at a CAGR of 15.8 percent over the period 2013-2018. Covered in this Report This report covers the present scenario ......
$2500